Olmesartan medoxomil, a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract.Olmesartan is a selective AT 1 subtype angiotensin II receptor antagonist.. Olmesartan medoxomil is described chemically as 2,3-dihydroxy-2-butenyl 4-(1 hydroxy-1- methylethyl)-2-propyl-1-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]imidazole-5 carboxylate, cyclic 2,3- carbonate.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products.
No appreciable changes in trough heart rate were observed with combination therapy.There are no trials of Olmesartan Medoxomil and Hydrochlorothiazide demonstrating reductions in cardiovascular risk in patients with hypertension, but at least one drug pharmacologically similar to olmesartan medoxomil has demonstrated such benefits, and hydrochlorothiazide demonstrated reduction of cardiovascular risk in patients with hypertension.The blood pressure lowering effect was maintained throughout the 24-hour period with olmesartan medoxomil once daily, with trough-to-peak ratios for systolic and diastolic response between 60 and 80%.The blood pressure lowering effect of olmesartan medoxomil, with and without hydrochlorothiazide, was maintained in patients treated for up to 1 year.
Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure:Data from one controlled trial and an epidemiologic study have suggested that high-dose olmesartan may increase cardiovascular (CV) risk in diabetic patients, but the overall data are not conclusive. Olmesartan (Benicar) is an oral medication used to treat high blood pressure. Olmesartan medoxomil and hydrochlorothiazide is not indicated for the initial therapy of hypertension [see Dosage and Administration ( 2)] . Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy.
It is practically insoluble in water and sparingly soluble in methanol. Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue olmesartan medoxomil and hydrochlorothiazide, taking into account the importance of the drug to the mother.Neonates with a history of in utero exposure to olmesartan medoxomil and hydrochlorothiazide: If they’re more severe or don’t go away, talk to your doctor or pharmacist.Call your doctor right away if you have serious side effects. Administration of olmesartan at least 4 hours prior to colesevelam hydrochloride decreased the drug interaction effect. Olmesartan has an highly safe track record. Be sure to tell your doctor about all medications, vitamins, or herbs you’re taking. There was a finding of increased CV mortality (adjudicated sudden cardiac death, fatal myocardial infarction, fatal stroke, revascularization death) in the olmesartan group compared to the placebo group (15 olmesartan vs. 3 placebo, HR 4.9, 95% confidence interval [CI], 1.4, 17), but the risk of non-fatal myocardial infarction was lower with olmesartan (HR 0.64, 95% CI 0.35, 1.18).The epidemiologic study included patients 65 years and older with overall exposure of > 300,000 patient-years. Ltd.
The makers of these brands are not affiliated with and do not endorse Umedica Laboratories Pvt.
Discard any unused suspension after 4 weeks.Do not flush medications down the toilet or pour them into a drain unless instructed to do so.
The randomized, placebo-controlled, double-blind ROADMAP trial (Randomized Olmesartan And Diabetes MicroAlbuminuria Prevention trial, n=4447) examined the use of olmesartan, 40 mg daily, vs. placebo in patients with type 2 diabetes mellitus, normoalbuminuria, and at least one additional risk factor for CV disease. [see Dosage and Administration (
Summary: Drug interactions are reported among people who take Eliquis and Hydrochlorothiazide together.
The antihypertensive effect had onset within 1 week and was near maximal at 4 weeks.